These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18676117)

  • 1. Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis.
    Stone CA; O'Leary N
    J Pain Symptom Manage; 2009 Feb; 37(2):246-58. PubMed ID: 18676117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of options for treating sialorrhea in amyotrophic lateral sclerosis.
    Banfi P; Ticozzi N; Lax A; Guidugli GA; Nicolini A; Silani V
    Respir Care; 2015 Mar; 60(3):446-54. PubMed ID: 25228780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Radiation Therapy and Botulinum Toxin Injections in the Management of Sialorrhea in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review.
    Shehee L; O'Rourke A; Garand KL
    J Clin Neuromuscul Dis; 2020 Jun; 21(4):205-221. PubMed ID: 32453096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease.
    Guidubaldi A; Fasano A; Ialongo T; Piano C; Pompili M; Mascianà R; Siciliani L; Sabatelli M; Bentivoglio AR
    Mov Disord; 2011 Feb; 26(2):313-9. PubMed ID: 21259343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
    Verma A; Steele J
    Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
    Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
    Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis.
    Neppelberg E; Haugen DF; Thorsen L; Tysnes OB
    Eur J Neurol; 2007 Dec; 14(12):1373-7. PubMed ID: 17941851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary glands radiotherapy to reduce sialorrhea in amyotrophic lateral sclerosis: dose and energy.
    Bourry N; Guy N; Achard JL; Verrelle P; Clavelou P; Lapeyre M
    Cancer Radiother; 2013 Jun; 17(3):191-5. PubMed ID: 23517881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of sialorrhea with botulinum toxin: an overview].
    Hagenah J; Kahl KG; Steinlechner S; Lencer R; Klein C
    Nervenarzt; 2005 Apr; 76(4):418-25. PubMed ID: 15448912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
    Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
    Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
    Costa J; Rocha ML; Ferreira J; Evangelista T; Coelho M; de Carvalho M
    J Neurol; 2008 Apr; 255(4):545-50. PubMed ID: 18283399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a treatment effective and safe for sialorrhea in people with amyotrophic lateral sclerosis (ALS)? Summary of a Cochrane Systematic Review.
    Cantisani TA
    Neurol Sci; 2023 Sep; 44(9):3083-3085. PubMed ID: 37326935
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and administration of treatment with botulinum neurotoxin for sialorrhoea in ALS patients: review of the literature and a proposal for tailored treatment.
    Stokholm MG; Bisgård C; Vilholm OJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):516-20. PubMed ID: 23984863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
    Young CA; Ellis C; Johnson J; Sathasivam S; Pih N
    Cochrane Database Syst Rev; 2011 May; (5):CD006981. PubMed ID: 21563158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of sialorrhea in amyotrophic lateral sclerosis.
    Tysnes OB
    Acta Neurol Scand Suppl; 2008; 188():77-81. PubMed ID: 18439227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review.
    Oliveira AF; Silva GA; Almeida DM
    Einstein (Sao Paulo); 2016; 14(3):431-434. PubMed ID: 27759834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease.
    Contarino MF; Pompili M; Tittoto P; Vanacore N; Sabatelli M; Cedrone A; Rapaccini GL; Gasbarrini G; Tonali PA; Bentivoglio AR
    Parkinsonism Relat Disord; 2007 Jul; 13(5):299-303. PubMed ID: 16807056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis/motor neurone disease: a systematic review.
    Squires N; Humberstone M; Wills A; Arthur A
    Dysphagia; 2014 Aug; 29(4):500-8. PubMed ID: 24847964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.
    Bushara KO
    Med Hypotheses; 1997 Apr; 48(4):337-9. PubMed ID: 9160288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis.
    McGeachan AJ; Hobson EV; Al-Chalabi A; Stephenson J; Chandran S; Crawley F; Dick D; Donaghy C; Ellis CM; Gorrie G; Hanemann CO; Harrower T; Jung A; Malaspina A; Morrison KE; Orrell RW; Talbot K; Turner MR; Williams TL; Young CA; Shaw PJ; McDermott CJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):1-9. PubMed ID: 27579520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.